Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance
Status
Conditions
Details and patient eligibility
About
Assess efficacy of piperacillin/tazobactam in reducing the cases of colonization and infection of bacteria.
Full description
Primarily, this study is designed to assess the efficacy of piperacillin/tazobactam in reducing the cases of colonization and infection of extended-spectrum betalactamases (ESBLs) producing E.coli or K pneumoniae, S aureus methicillin resistant (MRSA) and Enterococcus vancomycin resistant (VRE). Secondly, this study plans to determine the acquisition rate of ESBL producing E Coli or K pneumoniae, methicillin resistant S Aureus (MRSA) and vancomycin resistant Enterococcus spp (VRE), both pre- and post-intervention.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
All patients admitted in ICU will be enrolled (who qualify for treatment).
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal